产品
编 号:F618878
分子式:C18H17F2N3O3
分子量:361.34
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
结构图
联系客服
产品详情
生物活性:
BMS-986235 (LAR-1219) is a selective, orally active formyl peptide receptor 2 (FPR2) agonist, with EC50s of 0.41 nM and 3.4 nM for hFPR2 and mFPR2, respectively. BMS-986235 has potential for the prevention of heart failure.

体内研究:
BMS-986235 (LAR-1219) (0.3 mg/kg;口服;每日一次,持续 24 天) 可减轻小鼠左前降支 (LAD) 后的左心室和整体心脏重塑。 BMS-986235 (1 mg/kg;po) 处理显示 Cmax、T1/2、AUC0-inf,和生物利用度 (BA) 值分别为 160 nmol/L、0.68 小时、120 nmol/L?h 和 24%。Animal Model:Male C57BL/6 mice
Dosage:0.3 mg/kg
Administration:P.o.; daily for 24 days
Result:Left ventricle (LV) chamber remodeling is attenuated after myocardial infarction (MI). Reduced infarct length by 39% relative to vehicle.
Animal Model:Male mice (BALB/cCrSlc)
Dosage:1 mg/kg
Administration:P.o. (Pharmacokinetic Analysis)
Result:The Cmax, T1/2, AUC0-inf, and bioavailability (BA) values were 160 nmol/L, 0.68 hours, 120 nmol/L?h, and 24%, respectively.

体外研究:
BMS-986235 (LAR-1219) 抑制中性粒细胞趋化作用并刺激巨噬细胞吞噬作用,这是促进炎症消退的关键终点。
产品资料